Skip to content

Home
About
- Our Philosophy
- Team
Programs
Ventures
Press
Contact

Venture

SORT

Location

AllConnecticutNew York City

Program

AllABCTELabNYCThe Next Milestone

Attributes

AllWomen Founded

Affiliation

AllAlbert Einstein College of MedicineCity College of New YorkCity University of New YorkCold Spring Harbor LaboratoryColumbia UniversityHospital for Special SurgeryIcahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center (MSKCC)Mount SinaiNew York UniversityNew York University Medical CenterNY Genome CenterPolytechnic Institute of New York UniversityQuinnipiac UniversityRockefeller UniversityState University of New York DownstateStevens Institute of TechnologySUNYUniversity of ConnecticutWeill Cornell Medical CollegeYale University

Technology

AllBioinformatics ToolChemical SensorsDiagnosticDigital Health TechnologyDx and RxFunctional Food and DrinksHealthcare ServicesImmunotherapyIT SystemsMedical DeviceNutraceuticalPharmaceutical DrugPlatform Technology for Rapid DevelopmentResearch ToolTherapeuticTransplantationVaccinesWearable Assistive Technology

Indication

AllAllergy/AsthmaAssistive footwearAutoimmune & InflammationBasic ResearchBiologicBiomaterialsBotanical Treatment for Keloid DisorderCardiovascular DiseaseCentral Nervous System DisordersClinical ResearchClinical TrialsDelivery MethodDentistryDermatologyDevelopmental DisordersDisease SurveillanceDisordersDrug CompositionDrug DiscoveryEducationFibrosisGenetics & GenomicsHardware/SoftwareHealthcare ManagementHematologyImmunotherapyInfectious DiseaseMaternal healthMedical ImagingMetabolic DiseaseMobile Health IT PlatformMolecular DiagnosticMusculoskeletal DisordersNanotechnologyNephrologyNeurodegenerative DiseaseNeurologyNew method of sequencing mitochondrial DNANutritionObesityOncologyOrphan DiseasesOrthopaedicsPain ManagementPersonalized MedicinePharmacoeconomicsPhysical TherapyPlatform TechnologyProduction ProcessRegenerative MedicineResearch toolsRespiratory DiseaseSmall molecular inhibitors of Rel/NF-kBSurgical ToolTransplantationTwo-way text message based patient engagement, medical therapy management and care coordination platform (enterprise level)VaccineWomen’s health

Affiliations

Weill Cornell Medical College

Technologies

Therapeutic

Indication

Small molecular inhibitors of Rel/NF-kB

Website

jlabs.jnjinnovation.com

Additional Information

Women Founded

Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases.

ImmuneTarget, Inc. Team:

SORT

Location

AllConnecticutNew York City

Program

AllABCTELabNYCThe Next Milestone

Attributes

AllWomen Founded

Affiliation

AllAlbert Einstein College of MedicineCity College of New YorkCity University of New YorkCold Spring Harbor LaboratoryColumbia UniversityHospital for Special SurgeryIcahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer Center (MSKCC)Mount SinaiNew York UniversityNew York University Medical CenterNY Genome CenterPolytechnic Institute of New York UniversityQuinnipiac UniversityRockefeller UniversityState University of New York DownstateStevens Institute of TechnologySUNYUniversity of ConnecticutWeill Cornell Medical CollegeYale University

Technology

AllBioinformatics ToolChemical SensorsDiagnosticDigital Health TechnologyDx and RxFunctional Food and DrinksHealthcare ServicesImmunotherapyIT SystemsMedical DeviceNutraceuticalPharmaceutical DrugPlatform Technology for Rapid DevelopmentResearch ToolTherapeuticTransplantationVaccinesWearable Assistive Technology

Indication

AllAllergy/AsthmaAssistive footwearAutoimmune & InflammationBasic ResearchBiologicBiomaterialsBotanical Treatment for Keloid DisorderCardiovascular DiseaseCentral Nervous System DisordersClinical ResearchClinical TrialsDelivery MethodDentistryDermatologyDevelopmental DisordersDisease SurveillanceDisordersDrug CompositionDrug DiscoveryEducationFibrosisGenetics & GenomicsHardware/SoftwareHealthcare ManagementHematologyImmunotherapyInfectious DiseaseMaternal healthMedical ImagingMetabolic DiseaseMobile Health IT PlatformMolecular DiagnosticMusculoskeletal DisordersNanotechnologyNephrologyNeurodegenerative DiseaseNeurologyNew method of sequencing mitochondrial DNANutritionObesityOncologyOrphan DiseasesOrthopaedicsPain ManagementPersonalized MedicinePharmacoeconomicsPhysical TherapyPlatform TechnologyProduction ProcessRegenerative MedicineResearch toolsRespiratory DiseaseSmall molecular inhibitors of Rel/NF-kBSurgical ToolTransplantationTwo-way text message based patient engagement, medical therapy management and care coordination platform (enterprise level)VaccineWomen’s health

For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com

© 2024 FirstXFounder | Powered by Beaver Builder